Celltrion Pharm, Inc. (KOSDAQ: 068760)
South Korea
· Delayed Price · Currency is KRW 68,400
-1,000 (-1.44%)
Oct 8, 2024, 9:00 AM KST
Celltrion Pharm Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | 2015 - 2011 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 7, 2024 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | 2015 - 2011 |
| Market Capitalization | 2,812,755 | 8,705,449 | 1,423,608 | 2,161,702 | 2,080,517 | 794,235 | Upgrade
|
| Market Cap Growth | 91.48% | 511.51% | -34.14% | 3.90% | 161.95% | 110.08% | Upgrade
|
| Enterprise Value | 5,636,214 | 8,872,310 | 1,575,734 | 2,314,790 | 2,217,034 | 956,310 | Upgrade
|
| Last Close Price | 67900.00 | 210113.82 | 34361.10 | 52211.77 | 50320.64 | 19266.04 | Upgrade
|
| PE Ratio | 108.68 | 417.45 | 165.83 | -230.07 | 130.68 | -31.57 | Upgrade
|
| PS Ratio | 10.24 | 37.27 | 8.20 | 14.72 | 15.31 | 7.58 | Upgrade
|
| PB Ratio | 9.28 | 28.96 | 5.08 | 8.01 | 7.09 | 2.87 | Upgrade
|
| P/FCF Ratio | -2509.56 | -1518.88 | -540.71 | 304.21 | -185.06 | -28.07 | Upgrade
|
| P/OCF Ratio | 192.47 | 240.18 | 51.11 | 151.03 | -204.71 | -30.30 | Upgrade
|
| EV/Sales Ratio | 20.52 | 37.99 | 9.08 | 15.76 | 16.32 | 9.12 | Upgrade
|
| EV/EBITDA Ratio | 131.70 | 239.14 | 56.76 | 145.79 | 106.35 | -317.08 | Upgrade
|
| EV/EBIT Ratio | 195.12 | 375.45 | 106.91 | 731.16 | 257.41 | -63.40 | Upgrade
|
| EV/FCF Ratio | -2584.43 | -1548.00 | -598.49 | 325.75 | -197.20 | -33.80 | Upgrade
|
| Debt / Equity Ratio | 0.63 | 0.64 | 0.58 | 0.54 | 0.49 | 0.50 | Upgrade
|
| Debt / EBITDA Ratio | 4.48 | 5.20 | 5.83 | 9.26 | 6.92 | - | Upgrade
|
| Debt / FCF Ratio | -87.93 | -33.68 | -61.49 | 20.68 | -12.83 | -4.90 | Upgrade
|
| Asset Turnover | 0.52 | 0.46 | 0.38 | 0.32 | 0.30 | 0.24 | Upgrade
|
| Inventory Turnover | 4.20 | 3.65 | 2.96 | 1.99 | 1.19 | 0.90 | Upgrade
|
| Quick Ratio | 0.92 | 0.93 | 1.02 | 0.98 | 1.06 | 1.27 | Upgrade
|
| Current Ratio | 1.23 | 1.25 | 1.27 | 1.38 | 1.70 | 2.37 | Upgrade
|
| Return on Equity (ROE) | 8.91% | 7.21% | 3.13% | -3.33% | 5.51% | -9.00% | Upgrade
|
| Return on Assets (ROA) | 3.41% | 2.90% | 2.00% | 0.43% | 1.18% | -2.18% | Upgrade
|
| Return on Capital (ROIC) | 3.83% | 3.16% | 2.14% | 0.46% | 1.26% | -2.29% | Upgrade
|
| Earnings Yield | 0.92% | 0.24% | 0.60% | -0.43% | 0.76% | -2.66% | Upgrade
|
| FCF Yield | -0.08% | -0.07% | -0.18% | 0.33% | -0.54% | -3.56% | Upgrade
|
| Buyback Yield / Dilution | -0.23% | -0.19% | -0.40% | -1.38% | -18.02% | -33.27% | Upgrade
|
| Total Shareholder Return | -0.23% | -0.19% | -0.40% | -1.38% | -18.02% | -33.27% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.